Kabir M, Hu X, Martin T, Pokushalov D, Kim Y, Chen Y
Adv Sci (Weinh). 2024; 12(7):e2413377.
PMID: 39716936
PMC: 11831463.
DOI: 10.1002/advs.202413377.
Ter Laak A, Hillig R, Ferrara S, Korr D, Barak N, Lienau P
J Med Chem. 2024; 67(21):19282-19303.
PMID: 39450890
PMC: 11571114.
DOI: 10.1021/acs.jmedchem.4c01709.
Yang Z, Mogre S, He R, Berdan E, Ho Sui S, Hill S
NAR Cancer. 2024; 6(1):zcae003.
PMID: 38288445
PMC: 10823580.
DOI: 10.1093/narcan/zcae003.
Kumar V, Lakshman P, Prasad T, Manjunath K, Bairy S, Vasu A
Heliyon. 2024; 10(1):e23864.
PMID: 38226204
PMC: 10788520.
DOI: 10.1016/j.heliyon.2023.e23864.
Gajjela B, Zhou M
Curr Opin Chem Biol. 2023; 75:102323.
PMID: 37207401
PMC: 10524616.
DOI: 10.1016/j.cbpa.2023.102323.
Targeting bromodomain-containing proteins: research advances of drug discovery.
Pan Z, Zhao Y, Wang X, Xie X, Liu M, Zhang K
Mol Biomed. 2023; 4(1):13.
PMID: 37142850
PMC: 10159834.
DOI: 10.1186/s43556-023-00127-1.
Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review.
Czerwinska P, Mackiewicz A
Int J Mol Sci. 2023; 24(2).
PMID: 36674511
PMC: 9861003.
DOI: 10.3390/ijms24020995.
BAY-069, a Novel (Trifluoromethyl)pyrimidinedione-Based BCAT1/2 Inhibitor and Chemical Probe.
Gunther J, Hillig R, Zimmermann K, Kaulfuss S, Lemos C, Nguyen D
J Med Chem. 2022; 65(21):14366-14390.
PMID: 36261130
PMC: 9661481.
DOI: 10.1021/acs.jmedchem.2c00441.
BRPF1-KAT6A/KAT6B Complex: Molecular Structure, Biological Function and Human Disease.
Zu G, Liu Y, Cao J, Zhao B, Zhang H, You L
Cancers (Basel). 2022; 14(17).
PMID: 36077605
PMC: 9454415.
DOI: 10.3390/cancers14174068.
Hydrophobic cavity-directed azide-acetyllysine photochemistry for profiling non-histone interacting partners of bromodomain protein 1.
Kuwik J, Wagner S, Sudhamalla B, Debiec R, Islam K
RSC Chem Biol. 2022; 3(8):1061-1068.
PMID: 35975005
PMC: 9347360.
DOI: 10.1039/d2cb00043a.
Identification of the Highly Active, Species Cross-Reactive Complex I Inhibitor BAY-179.
Mowat J, Ehrmann A, Christian S, Sperl C, Menz S, Gunther J
ACS Med Chem Lett. 2022; 13(3):348-357.
PMID: 35300083
PMC: 8919281.
DOI: 10.1021/acsmedchemlett.1c00666.
TAF1 inhibitor Bay-299 induces cell death in acute myeloid leukemia.
Zhou L, Yao Q, Ma L, Li H, Chen J
Transl Cancer Res. 2022; 10(12):5307-5318.
PMID: 35116379
PMC: 8798726.
DOI: 10.21037/tcr-21-2295.
Fragment Hotspot Mapping to Identify Selectivity-Determining Regions between Related Proteins.
Smilova M, Curran P, Radoux C, von Delft F, Cole J, Bradley A
J Chem Inf Model. 2022; 62(2):284-294.
PMID: 35020376
PMC: 8790751.
DOI: 10.1021/acs.jcim.1c00823.
Optimization of Naphthyridones into Selective TATA-Binding Protein Associated Factor 1 (TAF1) Bromodomain Inhibitors.
Clegg M, Theodoulou N, Bamborough P, Chung C, Craggs P, Demont E
ACS Med Chem Lett. 2021; 12(8):1308-1317.
PMID: 34413961
PMC: 8366007.
DOI: 10.1021/acsmedchemlett.1c00294.
Functional Roles of Bromodomain Proteins in Cancer.
Boyson S, Gao C, Quinn K, Boyd J, Paculova H, Frietze S
Cancers (Basel). 2021; 13(14).
PMID: 34298819
PMC: 8303718.
DOI: 10.3390/cancers13143606.
The BRPF1 bromodomain is a molecular reader of di-acetyllysine.
Obi J, Lubula M, Cornilescu G, Henrickson A, McGuire K, Evans C
Curr Res Struct Biol. 2021; 2:104-115.
PMID: 33554132
PMC: 7861561.
DOI: 10.1016/j.crstbi.2020.05.001.
Interplay between cofactors and transcription factors in hematopoiesis and hematological malignancies.
Wang Z, Wang P, Li Y, Peng H, Zhu Y, Mohandas N
Signal Transduct Target Ther. 2021; 6(1):24.
PMID: 33468999
PMC: 7815747.
DOI: 10.1038/s41392-020-00422-1.
Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High-Grade Serous Ovarian Cancer.
Wan C, Keany M, Dong H, Al-Alem L, Pandya U, Lazo S
Cancer Res. 2020; 81(1):158-173.
PMID: 33158814
PMC: 7878408.
DOI: 10.1158/0008-5472.CAN-20-1674.
LSD1 inhibition induces differentiation and cell death in Merkel cell carcinoma.
Leiendecker L, Jung P, Krecioch I, Neumann T, Schleiffer A, Mechtler K
EMBO Mol Med. 2020; 12(11):e12525.
PMID: 33026191
PMC: 7645387.
DOI: 10.15252/emmm.202012525.
TAF1 plays a critical role in AML1-ETO driven leukemogenesis.
Xu Y, Man N, Karl D, Martinez C, Liu F, Sun J
Nat Commun. 2019; 10(1):4925.
PMID: 31664040
PMC: 6820555.
DOI: 10.1038/s41467-019-12735-z.